Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
NYSE:PHR
PHR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.07 - $32.76
Previous CloseN/A
Volume173.69K
Average Volume (3M)1.09M
Market Cap
$1.40B
Enterprise Value$1.58B
Total Cash (Recent Filing)$98.27M
Total Debt (Recent Filing)$4.75M
Price to Earnings (P/E)―
Beta1.51
Next Earnings
Dec 03, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding59,914,474
10 Day Avg. Volume709,404
30 Day Avg. Volume1,094,429
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.12
Enterprise Value/Revenue3.51
Enterprise Value/Gross Profit4.84
Enterprise Value/Ebitda230.37
Forecast
1Y Price Target
$34.33Price Target Upside47.66% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Bulls Say, Bears Say
Bulls Say
AcquisitionsPhreesia announced the acquisition of AccessOne, which is expected to provide a higher-margin avenue to monetize payments and significant cross-sell opportunity.
EarningsPhreesia reported its first positive GAAP EPS, highlighting improved profitability.
Growth PotentialThe growth outlook for Phreesia remains promising with new products and a growing healthcare provider base.
Bears Say
Market ReactionThe stock was down 11.5% after market as the deal is not necessarily cheap, and the company likely caught some investors off guard.
Revenue DeclinePhreesia traded down approximately 12% in the aftermarket, largely reflecting the sequential decline in subscription revenue per average healthcare system client and expectations for a larger adjusted EBITDA guidance raise.
Phreesia News
PHR FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $17.07 and its highest was $32.76 in the past 12 months.
What is Phreesia’s market cap?
Phreesia’s market cap is $1.40B.
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Dec 03, 2025 which is in 54 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on Sep 04, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.063 by $0.073.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is >-0.01.
How many shares outstanding does Phreesia have?
Phreesia has 59,914,474 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.063. Following the earnings report the stock price went down -9.869%.
Which hedge fund is a major shareholder of Phreesia?
Currently, no hedge funds are holding shares in PHR
Phreesia Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$34.33 (47.66% Upside)
$34.33 (47.66% Upside)
Blogger Sentiment
Bullish
PHR Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 494.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $809.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 7.3%
Last 30 Days ▲ 7.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.84%
12-Months-Change
Fundamentals
Return on Equity
-8.76%
Trailing 12-Months
Asset Growth
12.81%
Trailing 12-Months
Company Description
Phreesia
Phreesia (PHR) is a healthcare technology company that specializes in patient intake management solutions. The company operates primarily in the healthcare sector, offering a platform designed to streamline the patient registration process, enhance patient engagement, and improve overall operational efficiency for healthcare providers. Phreesia's core products include patient check-in solutions, appointment scheduling, insurance verification, and patient communication tools, all aimed at optimizing the patient experience and administrative workflows in medical practices.
PHR Company Deck
PHR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a predominantly positive sentiment driven by strategic acquisitions, significant revenue and income milestones, and promising product launches. Despite some challenges, such as flat revenue per client quarter-over-quarter and acquisition-related risks, the overall outlook remains optimistic.View all PHR earnings summariesPHR Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
PHR Stock 12 Month Forecast
Average Price Target
$34.33
▲(47.66% Upside)
Technical Analysis
Ownership Overview
5.61% Insiders
38.10% Mutual Funds
1.34% Other Institutional Investors
41.98% Public Companies and
Individual Investors